P H A R M ATA L E N T
MOVERS & SHAKERS
RICHARD JONES
ANKE LINNARTZ
Mereo BioPharma Group will welcome Richard Jones as Chief Financial Officer in early 2017. He joins Mereo from Shield Therapeutics, where he held the roles of Chief Financial Officer and Company Secretary. Prior to this, he pursued a career in investment banking.
Anke Linnartz has joined MorphoSys AG as Vice President and Head of Corporate Communications and Investor Relations. She succeeds Dr. Claudia Gutjahr-Löser and will report to Chief Financial Officer, Jens Holstein. Ms Linnartz previously worked for Gerresheimer, a global partner to the pharma and healthcare industries.
HELEN CARBERRY
Helen Carberry has been announced as Galderma’s new Human Resources Director, UK & Ireland. Prior to joining Galderma Helen held the position of Executive Director of HR with Mundipharma Research, in Cambridge and, before that role, was Head of Human Resources & Development at Lundbeck. She will be responsible for developing the HR function at Galderma into a more strategic business partner.
DR SIMON BOULTON
WHO’S GOING WHERE AND WHY THEY’RE GOING THERE. WORDS BY
Amy Schofield
2 8 | PH A R M A FI EL D.CO.U K
Artios Pharma has announced the appointment of Dr Simon Boulton as Vice President (VP) Science Strategy. He will assist the business development team in identifying and evaluating new pipeline opportunities from the global academic and industrial DDR network. He will also provide scientific leadership and support to the ongoing development of two lead DDR programmes that Artios has in-licensed from Cancer Research Technology.